PRR Share Price

Open 0.03 Change Price %
High 0.03 1 Day 0.00 0.00
Low 0.03 1 Week 0.00 0.00
Close 0.03 1 Month 0.00 0.00
Volume 4183727 1 Year -0.01 -25.00
52 Week High 0.04
52 Week Low 0.03
PRR Important Levels
Resistance 2 0.03
Resistance 1 0.03
Pivot 0.03
Support 1 0.03
Support 2 0.03
ASX Australia Most Active Stocks
AGO 0.01 0.00%
AGO 0.01 0.00%
AGO 0.01 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
FMG 5.21 2.76%
FMG 5.21 2.76%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
AVI 0.02 100.00%
AVI 0.02 100.00%
AVI 0.02 100.00%
AVI 0.02 100.00%
KTE 0.02 100.00%
SMD 0.02 100.00%
SMD 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
IVT 0.01 -50.00%
GDY 0.01 -50.00%
OEL 0.02 -33.33%
OEL 0.02 -33.33%
RLC 0.02 -33.33%
More..

Prima Biomed Ltd (ASX: PRR)

PRR Technical Analysis 5
As on 29th Jun 2017 PRR Share Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRR Target for June
1st Target up-side 0.03
2nd Target up-side 0.03
3rd Target up-side 0.03
1st Target down-side 0.03
2nd Target down-side 0.03
3rd Target down-side 0.03
PRR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.primabiomed.com.au
PRR Address
PRR
151 Macquarie Street
Level 7
Sydney, NSW 2000
Australia
Phone: 61 2 9276 1224
Fax: 61 2 9276 1284
PRR Latest News
Chart Watch: A Look at the Indicators For Prima BioMed Ltd (PRR.AX)   Baxter Review   - 29th Jun 17
Prima BioMed Bets Big on Cancer Drug IMP321 (PBMD)   Investopedia   - 17th Feb 17
Prima BioMed to Present at 2nd Annual Cancer Immunotherapy Conference   Marketwired (press release)   - 23rd Jan 17
Prima BioMed Announces Data From IMP321 AIPAC Clinical Trial in Breast Cancer   Marketwired (press release)   - 22nd Dec 16
Here's Why Prima BioMed Is Up 15%   Benzinga   - 12th May 16
Prima BioMed Ltd (PBMD) Gains as Analyst Sees Over 400% Upside   StreetInsider.com   - 31st Dec 15
Why Prima BioMed Limited skyrocketed 43% today   Motley Fool Australia   - 25th May 15
7 reasons Prima BioMed Limited is too risky   Motley Fool Australia   - 22nd May 15
Prima BioMed Announces Strategic Acquisition of Immutep SA   Marketwired (press release)   - 02nd Oct 14
Prima Biomed Ltd. ADR PBMD (US: Nasdaq)   Wall Street Journal   - 18th Apr 12
Interactive Technical Analysis Chart Prima Biomed Ltd ( PRR ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Prima Biomed Ltd
PRR Business Profile
Prima BioMed Ltd., a biotechnology company, researches, develops, and commercializes licensed medical biotechnology products in Australia. Its lead product includes CVac, a cancer vaccine for patients in remission, which has completed two human clinical trials. The company is also developing oral vaccine against human papilloma virus, a virus associated with development of cervical cancer. Prima BioMed Ltd. is based in Sydney, Australia.